The first reversible thrombolytic therapy for acute ischemic stroke on Basking Biosciences…
Location: United States, Ohio, Columbus
Total raised: $60.4M
Investors 1
| Date | Name | Website |
| 09.03.2024 | ARCH Ventu... | archventur... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.02.2024 | Series B | $55M | - |
| 07.12.2020 | Seed | $5.4M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 06.03.2024 | Latest Updates of Viva Biotech's Portfolio Companies | HONG KONG, March 6, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innova... | en.prnasia... |
| 01.02.2024 | Basking Biosciences Closes $55M Series B Round | COLUMBUS, OH, Basking Biosciences today announced the close of a $55 million financing. >> ... | vcnewsdail... |
| 01.02.2024 | Basking Biosciences Closes $55M Financing | Basking Biosciences, a Columbus, OH-based clinical-stage biopharmaceutical company developing a nove... | finsmes.co... |
| 20.10.2021 | Meet Ryan Helon, EVP of Investment Funds at Rev1 Ventures | Rev1 is a startup studio, providing guidance and connections, along with seed and early stage funds ... | vator.tv/n... |
| 07.12.2020 | Basking Biosciences Closes $5.4M Seed Financing | Basking Biosciences, Inc., a Columbus, Ohio-based biopharmaceutical company developing a next genera... | finsmes.co... |
| - | Basking Biosciences | “The first reversible thrombolytic therapy for acute ischemic stroke…” | fastfounde... |